IONSIonis Pharmaceuticals Inc
IONS
Ionis Pharmaceuticals Inc6,663
Mkt Cap
$11.73BVolume
2.92M52W High
$86.7452W Low
$23.95PE Ratio
-28.78IONS Fundamentals
Price
$70.99Prev Close
$71.32Open
$71.5150D MA
$79.69Beta
0.72Avg. Volume
2.15MEPS (Annual)
-$2.38P/B
23.70Rev/Employee
$673,117.69$12,595.28
Insider Selling: Ionis Pharmaceuticals (NASDAQ:IONS) EVP Sells 10,172 Shares of Stock
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Get Free Report) EVP Elizabeth Hougen sold 10,172 shares of the business's stock in a transaction dated Tuesday, March 17th. The stock was sold at an average price of $73.21, for a total value of $744,692.12. Following the completion of the sale, the...
MarketBeat·3d ago
Ionis Pharmaceuticals, Inc. $IONS Shares Sold by Groupama Asset Managment
Groupama Asset Managment reduced its position in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) by 8.5% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,061,777 shares...
MarketBeat·3d ago
Ionis Pharmaceuticals (NASDAQ:IONS) EVP Sells $744,692.12 in Stock
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Get Free Report) EVP Elizabeth Hougen sold 10,172 shares of the business's stock in a transaction dated Tuesday, March 17th. The stock was sold at an average price of $73.21, for a total transaction of $744,692.12. Following the completion of the...
MarketBeat·3d ago
Insider Selling: Ionis Pharmaceuticals (NASDAQ:IONS) EVP Sells 215,048 Shares of Stock
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Get Free Report) EVP Elizabeth Hougen sold 215,048 shares of the firm's stock in a transaction that occurred on Monday, March 16th. The shares were sold at an average price of $72.40, for a total transaction of $15,569,475.20. Following the transaction...
MarketBeat·3d ago
BlueCrest Capital Management Ltd Makes New Investment in Ionis Pharmaceuticals, Inc. $IONS
BlueCrest Capital Management Ltd purchased a new stake in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) in the 3rd quarter, according to its most recent filing with the SEC. The fund...
MarketBeat·4d ago
Alpine Global Management LLC Acquires 30,463 Shares of Ionis Pharmaceuticals, Inc. $IONS
Alpine Global Management LLC boosted its stake in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) by 119.8% during the third quarter, according to the company in its most recent filing with...
MarketBeat·4d ago
Ionis Pharmaceuticals, Inc. $IONS Shares Purchased by Jain Global LLC
Jain Global LLC raised its position in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) by 3,037.4% in the third quarter, according to the company in its most recent Form 13F filing...
MarketBeat·6d ago
BlueCrest Capital Management Ltd Takes Position in Ionis Pharmaceuticals, Inc. $IONS
BlueCrest Capital Management Ltd purchased a new position in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) in the 3rd quarter, according to the company in its most recent filing with the...
MarketBeat·7d ago
Cinctive Capital Management LP Invests $11.37 Million in Ionis Pharmaceuticals, Inc. $IONS
Cinctive Capital Management LP purchased a new stake in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) during the 3rd quarter, according to the company in its most recent Form 13F filing...
MarketBeat·7d ago
Boone Capital Management LLC Takes $27.34 Million Position in Ionis Pharmaceuticals, Inc. $IONS
Boone Capital Management LLC purchased a new position in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) in the 3rd quarter, according to the company in its most recent 13F filing...
MarketBeat·7d ago
<
1
2
...
>